Salivary Gland Uptake on 18 F‐Florbetaben PET Did Not Demonstrate Additional Diagnostic Value for Alzheimer's Disease
Brain and Behavior · 2026
DOI: 10.1002/brb3.71199 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2026. Verfasst von Hyun Woo Kwon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Korea University Ansan Hospital, Ansan, South Korea. Hauptthemen laut MEDLINE: Alzheimer Disease, Positron-Emission Tomography, Stilbenes, Aniline Compounds. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Objectives
Saliva, like other body fluids, has been investigated as a source of biomarkers for Alzheimer's disease (AD) due to its accessibility. Recently, decreased amyloid‐PET uptake in the salivary glands of patients with AD was reported, prompting interest in the potential clinical relevance of that finding. This study evaluates the association between salivary gland uptake on 1 8 F‐florbetaben PET and cortical amyloid burden and assesses its diagnostic value.
Methods
We retrospectively analyzed 73 patients who underwent 18 F‐florbetaben PET imaging. Salivary gland uptake (SUVR SG ) was measured and compared with the cortical amyloid burden, severity of dementia, and clinical diagnoses (cognitively normal, mild cognitive impairment, and dementia). Diagnostic performance was assessed using receiver operating characteristic (ROC) curve analyses.
Results
The mean SUVR SG was 1.43 ± 0.29, with no significant differences based on the cortical amyloid burden, severity of dementia, or clinical diagnosis. SUVR SG did not correlate with the cortical amyloid burden (ρ = −0.103, p > 0.05). The area under the ROC curve and volume under the ROC surface indicated that SUVR SG had poor diagnostic performance.
Conclusions
Salivary gland uptake on 18 F‐florbetaben PET was not associated with the cortical amyloid burden or clinical stage of AD, and it did not demonstrate diagnostic value. Further research is needed to explore its biological significance and standardization methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Korea University Ansan Hospital, Ansan, South Korea.
- Department of Psychiatry, Korea University Ansan Hospital, Ansan, South Korea.
- Department of Neurology, Korea University Ansan Hospital, Ansan, South Korea.
Zitieren
APA
Kwon, H. W., Jung, S., Shin, C., Kim, J. H., & Park, M. H. (2026). Salivary Gland Uptake on 18 F‐Florbetaben PET Did Not Demonstrate Additional Diagnostic Value for Alzheimer's Disease. Brain and Behavior. https://doi.org/10.1002/brb3.71199
Vancouver
Kwon HW, Jung S, Shin C, Kim JH, Park MH. Salivary Gland Uptake on 18 F‐Florbetaben PET Did Not Demonstrate Additional Diagnostic Value for Alzheimer's Disease. Brain and Behavior. 2026. doi:10.1002/brb3.71199
BibTeX
@article{Kwon2026,
author = {Kwon, Hyun Woo and Jung, Saim and Shin, Cheolmin and Kim, Jong Hun and Park, Moon Ho},
title = {Salivary Gland Uptake on 18 F‐Florbetaben PET Did Not Demonstrate Additional Diagnostic Value for Alzheimer's Disease},
journal = {Brain and Behavior},
year = {2026},
doi = {10.1002/brb3.71199}
}
EUVIMED